YARROW BIOSCIENCE, INC. Investing Cash Flow
YARROW BIOSCIENCE, INC. (YARW) reported Investing Cash Flow of $5.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $300.00K, a 93.58% decline year-over-year.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $4.70M, a 76.30% decline year-over-year.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $4.67M, a 75.42% decline year-over-year.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $19.83M.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$57.35M, a 466.08% decline from fiscal 2022.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) investing activities for fiscal 2022 was $15.67M, a 1425.51% increase from fiscal 2021.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) investing activities for fiscal 2021 was $1.03M, a 98.85% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. net cash provided by (used in) investing activities for fiscal 2020 was $89.11M, a 112.82% increase from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $300.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | $5.00M 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | $4.70M S-4/A · filed 2026-06-03 | |||||||
| 2025-12-31 | $37.37M S-4/A · filed 2026-06-03 | |||||||
| 2025-06-30 | $4.67M derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | $24.51M 10-Q · filed 2026-08-13 | $37.24M derived: sum of 3 quarters · filed 2026-08-13 | $32.42M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $19.83M S-4/A · filed 2026-06-03 | $32.57M derived: sum of 2 quarters · filed 2026-06-03 | $27.75M derived: sum of 3 quarters · filed 2026-06-03 | $46.77M derived: sum of 4 quarters · filed 2026-06-03 | ||||
| 2024-12-31 | $12.74M derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | $7.91M derived: sum of 2 quarters · filed 2026-06-03 | $26.93M derived: sum of 3 quarters · filed 2026-06-03 | $23.36M S-4/A · filed 2026-06-03 | ||||
| 2024-09-30 | -$4.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $14.20M derived: sum of 2 quarters · filed 2025-08-14 | $10.63M 10-Q · filed 2024-11-07 | -$51.73M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-06-30 | $19.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $15.45M 10-Q · filed 2025-08-14 | -$46.90M derived: sum of 3 quarters · filed 2025-08-14 | -$46.90M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$3.57M 10-Q · filed 2025-05-08 | -$65.92M derived: sum of 2 quarters · filed 2025-05-08 | -$65.92M derived: sum of 3 quarters · filed 2025-05-08 | -$65.92M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$62.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$62.35M derived: sum of 2 quarters · filed 2025-03-06 | -$62.35M derived: sum of 3 quarters · filed 2025-03-06 | -$57.35M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $5.00M 10-Q · filed 2024-11-07 | $5.00M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $5.00M 10-Q · filed 2024-08-14 | $5.00M derived: sum of 3 quarters · filed 2024-08-14 | $4.92M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $5.00M 10-Q · filed 2024-05-09 | $5.00M derived: sum of 2 quarters · filed 2024-05-09 | $4.92M derived: sum of 3 quarters · filed 2024-05-09 | $4.92M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$85.00K derived: sum of 2 quarters · filed 2024-03-01 | -$85.00K derived: sum of 3 quarters · filed 2024-03-01 | $15.67M 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$86.00K derived: sum of 2 quarters · filed 2023-11-13 | $15.67M 10-Q · filed 2023-11-13 | $16.60M 10-Q · filed 2022-11-14 | $15.67M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $15.75M 10-Q · filed 2023-08-14 | $16.69M 10-Q · filed 2022-08-12 | $15.75M derived: sum of 3 quarters · filed 2023-08-14 | $15.75M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $15.75M 10-Q · filed 2023-05-11 | $16.69M 10-Q · filed 2022-05-12 | $15.75M derived: sum of 2 quarters · filed 2023-05-11 | $15.75M derived: sum of 3 quarters · filed 2023-05-11 | $16.78M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $1.03M derived: sum of 3 quarters · filed 2023-03-14 | $1.03M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.03M derived: sum of 2 quarters · filed 2022-11-14 | $1.03M 10-Q · filed 2022-11-14 | $3.03M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.03M 10-Q · filed 2022-08-12 | $3.03M derived: sum of 3 quarters · filed 2022-08-12 | $3.03M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | $2.00M derived: sum of 2 quarters · filed 2022-05-12 | $2.00M derived: sum of 3 quarters · filed 2022-05-12 | $23.13M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $2.00M derived: sum of 2 quarters · filed 2022-03-17 | $23.13M derived: sum of 3 quarters · filed 2022-03-17 | $89.11M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $21.13M derived: sum of 2 quarters · filed 2021-11-10 | $87.11M 10-Q · filed 2021-11-10 | $93.14M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $21.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $87.11M 10-Q · filed 2021-08-12 | $93.14M derived: sum of 3 quarters · filed 2021-08-12 | $88.46M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $65.98M 10-Q · filed 2021-05-06 | $72.01M derived: sum of 2 quarters · filed 2021-05-06 | $67.34M derived: sum of 3 quarters · filed 2021-05-06 | $100.11M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $1.36M derived: sum of 2 quarters · filed 2021-03-04 | $34.13M derived: sum of 3 quarters · filed 2021-03-04 | $41.87M 10-K · filed 2021-03-04 | $41.37M 10-K · filed 2020-03-03 | |||
| 2019-09-30 | -$4.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $28.10M derived: sum of 2 quarters · filed 2020-11-05 | $35.84M 10-Q · filed 2020-11-05 | $28.30M 10-Q · filed 2019-10-31 | $53.88M derived: sum of 4 quarters · filed 2021-03-04 | |||
| 2019-06-30 | $32.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $40.51M 10-Q · filed 2020-08-06 | $42.91M 10-Q · filed 2019-08-01 | $58.56M derived: sum of 3 quarters · filed 2021-03-04 | $66.86M derived: sum of 4 quarters · filed 2021-03-04 | |||
| 2019-03-31 | $7.74M 10-Q · filed 2020-05-11 | $27.50M 10-Q · filed 2019-05-02 | $25.79M derived: sum of 2 quarters · filed 2021-03-04 | $34.09M derived: sum of 3 quarters · filed 2021-03-04 | $41.85M derived: sum of 4 quarters · filed 2021-03-04 | |||
| 2018-12-31 | $18.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $26.35M derived: sum of 2 quarters · filed 2021-03-04 | $34.11M derived: sum of 3 quarters · filed 2021-03-04 | -$11.76M 10-K · filed 2021-03-04 | -$33.88M 10-K · filed 2019-02-28 | |||
| 2018-09-30 | $8.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $16.06M derived: sum of 2 quarters · filed 2019-10-31 | -$29.80M 10-Q · filed 2019-10-31 | -$23.53M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | $7.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$38.10M 10-Q · filed 2019-08-01 | -$31.83M derived: sum of 3 quarters · filed 2020-03-03 | -$68.13M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | -$45.87M 10-Q · filed 2019-05-02 | -$45.78M 10-Q · filed 2018-05-09 | -$39.59M derived: sum of 2 quarters · filed 2020-03-03 | -$75.89M derived: sum of 3 quarters · filed 2020-03-03 | -$68.54M derived: sum of 4 quarters · filed 2020-03-03 | |||
| 2017-12-31 | $6.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$30.03M derived: sum of 2 quarters · filed 2020-03-03 | -$22.68M derived: sum of 3 quarters · filed 2020-03-03 | -$15.09M 10-K · filed 2020-03-03 | -$15.06M 10-K · filed 2018-03-28 | |||
| 2017-09-30 | -$36.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$28.95M derived: sum of 2 quarters · filed 2018-11-07 | -$21.36M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $7.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $14.94M 10-Q · filed 2018-08-01 | ||||||
| 2017-03-31 | $7.59M 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | -$37.52M 10-K · filed 2019-02-28 | -$37.49M 10-K · filed 2018-03-28 | ||||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |